Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q2 2023 call → NOThe question asks whether management's account of the reported period is built around real business activity that crossed from not-happening to happening partway through the period, and whether management makes clear the climb is incomplete and the printed numbers lag it. Let me analyze the transcript: 1. The period is H1 2023 (six months ended June 30, 2023). 2. The Janssen agreement was signed - the press release says "following the successful completion of a global license agreement with Janssen" - the deal was announced, and the $30 million upfront was received. The first equity tranche of $5 million was received after shareholder approval. But the agreement itself - was it signed during the period? The call says "we are pleased to have already received the first equity charge of $5 million following shareholder approval" - this seems to be after the period end (the cash balance as of June 30 doesn't include the $30 million upfront or $5 million equity tranche, which were received "meanwhile" - i.e., after June 30). So the Janssen deal closed after the period end, not during it. 3. The MD Anderson trial - "In July, the first patient was injected in the newest MDLA study" - that's after the period end (July). 4. The NANORAY-312 trial - ongoing, no new start mentioned in the period. 5. The EIB discussions - "subsequent to the company's licensing agreement executed with Janssen" - after period end. So what actually started during the period? The transcript doesn't clearly describe a real business activity that began during H1 2023 and is transacting. The Janssen deal was executed (the agreement) but the cash came after June 30. The first patient injection in the MD Anderson trial was in July (after period end). The financial results show revenue of EUR3.3 million for H1 2023 vs EUR1.3 million in H1 2022 - but this is mainly from research tax credit and the LianBio supply and collaboration agreement. Management doesn't describe a concrete business activity that began during the period and is now transacting at a higher level than the reported numbers show. The Janssen deal is a signing, with the upfront received after period end. The MD Anderson trial first patient was July (after period).
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.